The SFB/Transregio "Aortic Diseases", will be working on basic and clinical research on expanding the understanding of fundamental principles in the pathogenesis of aortic diseases.
The SFB/Transregio "Cellular mechanisms of antibiotic action and production" intends to further investigate the biochemical production and action mechanisms of antibiotics.
More read the press release here
ImmunoSensation Scientist, Dr. Bernardo Franklin was feature in a Nature article titled "Europe is a top destination for many researchers". The article interviewed scientists from different parts of the world who are working in the EU.
“Science is not a recognized profession in Brazil, where I come from,” says Bernardo Franklin, an immunologist at the University of Bonn in Germany. “In Germany, PhD students are given working contracts, with regulations that provide them with insurances, pension and other benefits, and protect them from exploitation and abusive supervisors.”
Read the full article by clicking this link.
Neurodegeneration meets neuroinflammation: the mutual interactions between immune cells and neurons.
In this year's Venusberg Meeting on Neuroinflammation a special emphasis will be put on the interaction between neurodegenerative and neuroinflammatory mechanisms.
Speakers from all areas of neuroinflammation will present the most recent findings and developments in order to stimulate vivid and challenging discussions. More information on the program, venue and registration can be found at the website of the DZNE www.dzne.de/Venusbergmeeting2019
Date and Time:
9th May 2019 (9.00 a.m) - 11 May 2019 (5.00 p.m)
On the 29th of April 2019, Prof. Dr. Dr. h. c. Michael Hoch, Rector of the University of Bonn opened the exhibition Immun-Sinn at the University Museum of the University of Bonn. Immun-Sinn is an exhibition prepared by ImmunoSensation scientists and looks into the different aspects of immunology, starting with the history of immunotherapy, Alzheimer’s disease, influence of western diet on the immune system, tropical diseases and technological advancements in the field of immunology. The opening ceremony was attended by guests from different institutions in Bonn and also included PhD and Masters students. The exhibition will run from the 2nd of May till the 30th of June.
A TV spot about Cluster research conducted by the Institute of Innate Immunity (Prof. Eicke Latz and Dr. Anette Christ) can be found here:
It will provide you with information on how eating fast food will activate your immune system.
An exhibition showing milestones in the field of immunology at the University of Bonn’s Museum from the 2nd of May to the 30th of June 2019
The exhibition titled ImmunSinn, is aimed at bringing immunology closer to the people covering the topics of immunotherapy, Alzheimer’s disease, the influence of western diet on our health, parasitic diseases and technological advances in immunology. On display are photos, 3D models, parasitic worms and informative posters that will take you from the 1860s to the present day.
The exhibition looks into some milestones in the field of immunotherapy, comparing the late 19th, the early 20th and the 21st centuries. We feature the first doctor who tried to harness the power of the immune system to fight cancer by using bacterial infection. Unknown to most people, he was a professor of surgery at the University Hospital Bonn. In 1867, Professor of Surgery, Carl David Wilhelm Busch, in his quest to cure a patient with an inoperable tumor of the neck, knowingly and purposefully exposed her to bacterial infection. This was after the observation that an episode of bacterial skin infection called erysipelas caused tumors to shrink. His treatment was at first successful and he was able to reduce the tumor size, but unfortunately, after a short while it grew back and the patient later succumbed to cancer. We also feature 21st century Busch-like immunotherapy, but more refined, this time using nucleic acids that mimic viral infections to induce a specific immune response that fights cancers.
During the late 19th century some doctors used live bacteria as a way to shrink and treat tumors. At that point in time, the knowledge on why and how this worked was not known. By the early 1900s, the use of live bacteria was replaced with its products. Since then, the field of immunology has grown and more information on host – pathogen interactions are now available. This has enabled scientists to move from directly using live bacteria organisms, to the production of specific molecules that are recognized by immune cells in the same way as pathogens.
In developing countries, the most common causes of death are infectious diseases, while the developed nations have more lifestyle associated disease. As a representative disease of the western lifestyle, an atherosclerosis model is displayed which compares a healthy versus a clogged artery. For the developing world a collection of parasitic diseases that are endemic to the tropics and subtropics are displayed.
Prof. Schultze: “The exhibition looks into the developments that have taken place in the field of immunology over the last 100 years. It also gives a peak into the future, from using microscopes, like the 100 year old one on display, to the latest technology of single cell genomics”.
The exhibition has been put together by a team of scientists from ImmunuSensation2, like Dr. Anette Christ and Prof. Joachim Schultze (photographed at the exhibition), researcher from the Institute for Medical Humanities and compiled by Dr. Patricia Korir with support and advice from the speakers of the Cluster.
For those who would like to know more on specific topics in the exhibition, there will be public lectures inside the museum on the below listed topics and dates at 6 PM:
•23rd May, Dr. Anette Christ, The effects of western diet on our health, Institute of Innate Immunity, University Hospital Bonn
•6th June, Prof. Dr. med. Joachim Schultze, Single cell genomics: from one cell to the patient, LIMES, University of Bonn
•13th June, Prof. Dr. med. Michael Heneka, Alzheimer’s disease, Department of Neurodegenerative Diseases and Gerontopsychiatry at the University of Bonn University Hospital Bonn
Dr. Patricia Jebett Korir
ImmunoSensation Cluster of Excellence, University of Bonn
Press and Public Relations
Venusberg - Campus 1, 53127 Bonn,
+49 228 287-51283
An open PostDoc Position is available in the Wilhelm Lab in the Insitute of Clincal Chemistry and Clinical Pharmacology.
We are seeking a highly motivated postdoctoral fellow to conduct research on the fundamental aspects of nutritional regulation of the immune system. The Project aims to understand how different diets are able to shape the function of the immune system. In particular the work aims to identify how dietary-derived metabolites shape the biology of tissue resident immune cells such as innate lymphoid cells (ILC) in health and disease. The candidate will have opportunities to obtain additional external funding and develop an independent research program during postdoctoral training.
Find more information in the attached poster.
To find outstanding PhD students for the IITB program and the BIGS Immunoscience and Infection, we invite all interested students in our Selection Symposium. This will take place in May 2019 for the final round applicants. The Selection Symposium will include interviews with a Selection Committee, oral or poster presentations of the applicants and interviews with the PIs in whose labs postitions are available.
Please check our Recruitment Section for further information on how to apply.
Start of the PhD positions is planned for July 1, 2019 or later.
Neglected tropical diseases such as Lymphatic filariosis are common in tropical and subtropical areas. Here mostly poor people are affected.
An international consortium with a contribution of scientists from the Cluster of Excellence ImmunoSensation identified a new substance ABBV-4083 in the fight against adult worms, the cause of lymphatic filariosis.
Dr. Marc Hübner and Prof. Hörauf are working in the Institute of Medical Microbiology, Immunology and Parasitology at the University Hospital Bonn.
You can find the german press release here.
Publication: Mark J. Taylor, Thomas W. von Geldern, Louise Ford, Marc P. Hübner, Kennan Marsh, Kelly L. Johnston, Hanna T. Sjoberg, Sabine Specht, Nicolas Pionnier, Hayley E. Tyrer, Rachel H. Clare, Darren A. N. Cook, Emma Murphy, Andrew Steven, John Archer, Dominique Bloemker, Franziska Lenz, Marianne Koschel, Alexandra Ehrens, Haelly M. Metuge, Valerinne C. Chunda, Patrick W. Ndongmo Chounna, Abdel J. Njouendou, Fanny F. Fombad, Robert Carr, Howard E. Morton, Ghaith Aljayyoussi, Achim Hoerauf, Samuel Wanji, Dale J. Kempf, Joseph D. Turner, Stephen A. Ward: Preclinical development of an oral anti-Wolbachia macrolide drug for the treatment of lymphatic filariasis and onchocerciasis, Science Translational Medicine, DOI: 10.1126/scitranslmed.aau2086
We are pleased to announce that female postdoctoral researchers and junior group leaders have the chance to apply for a fellowship for an One-on-One Career Coaching.
When: Starting in May
Where: Bonn (Humbroichweg 1A, 53227 Bonn) or via Skype
- Reflecting your own position and competences
- Finding your own career strategy
- Discussing your funding profile
- Get feedback on your CV
- and much more
You can decide the number and duration of your sessions (totalling to 10 hours).
!Take the chance to define your own career path!
Please send a letter of motivation, a description of your scientific work (needed for the coaching) together with the completed application form to email@example.com
Application deadline: April 05, 2019
Dear Cluster members and associated scientists,
We are pleased to announce that application for fellowships for the 8th DGfI Translational Immunology School 2019 is open! The fellowship covers the registration fee including courses, accommodation, full board and social program.
What? 8th DGfI Translational Immunology School 2019
When? April 11-13, 2019
Further information you can find at https://dgfi.org/akademie-fuer-immunologie/translational-school/.
Application deadline: March 10, 2019
Applications will only be accepted via our eTraining system. To open your application, please send a short email to firstname.lastname@example.org.
A team formed by researchers from the Institute of Innate Immunity, the Institute of Experimental Immunology of the University of Bonn, and the University of Massachusetts Medical School have unraveled a long standing enigma in crystal-induced chronic inflammation.
It has been known, since 1850, that eosinophil infiltration into tissues results in the accumulation of large extracellular crystals known as Charcot-Leyden crystals (CLCs). CLCs have now been extensively described in the lungs of asthmatics patients as well as in patients with allergic reactions, helminthic infections and in the nose of chronic rhinosinusitis patients. Research on this topic has been considerably slow, for example, it took another 120 years for the biochemical characterization of these crystals, formed by a protein Galectin-10, which is enriched in eosinophil granules. Since then, another gap in knowledge was that their function or activity remained unknown. Whether these crystals are merely a marker of eosinophil demise, or play any role in the disease progression.
The new study published this week in the Journal of Immunology shows that Charcot-Leyden crystals induce a strong inflammatory response driven by interleukin-1 after the activation of the pattern recognition receptor NLRP3 and formation of inflammasomes. The study suggests that a product of eosinophil degranulation can sustain immune activity, which could have important implications for the development of chronic diseases such as allergic asthma, a chronic airway inflammatory disease that affects 8-12% of people in Europe.
Dr. Eva Bartok from the Institute of Clinical Chemistry and Pharmacology was awarded the Universitätsgesellschaft Bonn (UGB) Bonner Preis für Medizin (Bonner Prize for Medicine) for her outstanding doctoral thesis in the field of medicine. The prize which is sponsored by Prof. Dr. Rolf Dederich and the UGB has been awarded annualy since 2012 and carries a cash reward of 5000 euros.
The scientists examined the coding genes of three families that are not related to each other and are of different ancestry. A total of eight relatives showed the typical symptoms of hair loss. All those affected had mutations in the LSS gene. “This gene encodes lanosterol synthase - LSS for short,” said Prof. Dr. Regina C. Betz from the Institute of Human Genetics at the University Hospital of Bonn. “The enzyme plays a key role in cholesterol metabolism.” However, the cholesterol blood values of those affected are not changed. Betz: “There is an alternative metabolic pathway for cholesterol, which plays an important role in the hair follicle and is not related to blood cholesterol levels."
The much awaited Excellence Strategy funding decision by the DFG was received with cheers and applause! As the Rector of the University of Bonn, Prof. Michael Hoch, read the list of the 6 funded Excellence Clusters from the DFG website, the room was filled with joy and cheers!
ImmunoSensation² and 5 other Clusters were successful in their application. This was a significant moment, as the University of Bonn was the only University in Germany to receive funding for six Clusters of Excellence.
We congratulate all ImmunoSensation scientists for their hard work and we look forward to achieving greater heights!!
We also congratulate: The Hausdorff Center for Mathematics, Beyond Slavery and Freedom, PhenoRob, ML4Q and ECONtribute!
Change in technology has brought with it convenience in the medical sector, with just a click of a button, patients and doctors have access to a lot of information.
As part of the 200 years jubilee celebrations of the University of Bonn, Immunosensation together with the Medical Faculty organized an open lecture for the public on this topic. Prof. Nicolas Wernert Dean of the Faculty of Medicine, gave a public lecture on the actual trends in the digitalization of medicine. His talk broadly covered actual tread starting from intergration of multi-omics, 3D printing of organs and tumors, standard Health-Apps on mobile phones to minimal invasive surgery using robotics. The lecture was directly followed by a podium discussion with experts in the fields related to it.
The topic of digitalization is a sensitive one and with it alot of ethical and legal implications, therefore, to efficiently discuss this topic, the members of the panel consisted of experts from the legal sector, ethics, medical and private sector. Members of the podium were : Prof. Dr. Nicolas Wernert - Dean Faculty of Medicine, University of Bonn, Prof. Dr. Dr. Mariacarla Gadebusch Bondio – Director, Institute of Medical History, University Hospital Bonn, Katrin Reuter – Founder trackle GmbH, Prof. Dr. Markus Nöthen – Director, Institute of Human Genetics, University of Bonn and Prof. Dr. iur. Dirk Böhmann - Legal advisor for medical and labor laws, German Association of University Professors and Lecturers. The event was moderated by Jan Niklas Hansen, Doctoral candidate at the Institute of Innate Immunity, University of Bonn.
The chemotactic protein CCL17 attracts immune cells to where they are currently needed. Doctors have long known: A high level of this substance in the body indicates an allergic reaction. A team of scientists led by the University of Bonn has now discovered a completely new function: CCL17 also influences signal transmission in the brain. There may even be a molecular link to autism. The results have now been published in the journal “GLIA”.
The article which they published in Glia is available online DOI: 10.1002/glia.23507